Thursday, May 1, 2014
Publication and contact
benthamiana to produce glycosylated IgMs
benthamiana could generate glycosylated IgMs to treat human diseases. In
engineered N. benthamiana plants lacking plant-specific glycosylation,
transfection with vectors encoding IgM components resulted in the production
of a therapeutic IgM, PAT-SM6,
in high picomolar yields per gram of plant material. The glycosylation
pattern of the plant-generated PAT-SM6 was comparable to that of PAT-SM6 produced
in a human cell line. In a human lung cancer cell line, the plant- and human
cell line-generated forms of PAT-SM6 showed comparable inhibitory action
against their target, heat shock
70 kDa protein 5 (glucose-regulated
protein, 78 kDa; HSPA5;
Next steps include using the engineered plants to generate IgMs against
antibiotic-refractory bacterial infections.
Patrys Ltd. has
PAT-SM6, a human mAb that binds HSPA5 and imports low-density
lipoprotein into cancer cells, in Phase I/II testing to treat
multiple myeloma (MM) and Phase I trials to treat melanoma.
Patrys, AstraZeneca plc
and Debiopharm Group
a human IgM mAb that binds to gastric cancer cells expressing CD55SC-1,
in Phase I/II testing to treat gastric cancer and in preclinical development
for solid tumors.
Published online May 1, 2014
Patented; licensing status
Loos, A. et al. Proc.
Natl. Acad. Sci. USA; published online March 31, 2014;
Contact: Herta Steinkellner, University of Natural Resources
and Applied Life Sciences, Vienna, Austria
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]